Literature DB >> 19568789

3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase.

Véronique Calleja1, Michel Laguerre, Banafshé Larijani.   

Abstract

New developments regarding the structure and in vivo dynamics of protein kinase B (PKB/Akt) have been recently exposed. Here, we specifically review how the use of multi-disciplinary approaches has resulted in reaching the recent progress made to relate the quaternary structure of PKB to its in vivo function. Using X-ray crystallography, the structure of PKB pleckstrin homology (PH) and kinase domains was determined separately. The molecular mechanisms involved in (a) the binding of the phosphoinositides to the PH domain and (b) the activation of the kinase with the rearrangement of the catalytic site and substrate binding were determined. In vitro, nuclear magnetic resonance and circular dychroism studies gave complementary information on the interaction of the PH domain with the phosphoinositides. However, the molecular nature and the function of the interactions between the PKB domains could not be deduced from the X-ray data since the full-length PKB has not been crystallised. In vitro, dynamic information on the inter-domain conformational changes related to PKB activation states emerged with the use of tandem mass spectrometry. Cell imaging and Förster resonance energy transfer provided in vivo dynamics. Molecular modelling and dynamic simulations in conjunction with mutagenesis and biochemical analysis were used to investigate the complex interactions between the PKB domains in vivo and understand at the molecular level how it linked to its activity. The compilation of the information obtained on the 3-D structure and the spatiotemporal dynamics of this widely studied oncogene could be applied to the study of other proteins. This inter-disciplinary approach led to a more profound understanding of PKB complex activation mechanism in vivo that will shed light onto new ideas and possibilities for modulating its activity.

Entities:  

Year:  2009        PMID: 19568789      PMCID: PMC2682354          DOI: 10.1007/s12154-009-0016-8

Source DB:  PubMed          Journal:  J Chem Biol        ISSN: 1864-6158


  64 in total

Review 1.  FRET-based biosensors for protein kinases: illuminating the kinome.

Authors:  Jin Zhang; Michael D Allen
Journal:  Mol Biosyst       Date:  2007-08-21

2.  Interdomain conformational changes in Akt activation revealed by chemical cross-linking and tandem mass spectrometry.

Authors:  Bill X Huang; Hee-Yong Kim
Journal:  Mol Cell Proteomics       Date:  2006-03-09       Impact factor: 5.911

3.  Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors.

Authors:  M Andjelković; T Jakubowicz; P Cron; X F Ming; J W Han; B A Hemmings
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.

Authors:  Craig W Lindsley; Zhijian Zhao; William H Leister; Ronald G Robinson; Stanley F Barnett; Deborah Defeo-Jones; Raymond E Jones; George D Hartman; Joel R Huff; Hans E Huber; Mark E Duggan
Journal:  Bioorg Med Chem Lett       Date:  2005-02-01       Impact factor: 2.823

5.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

6.  Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter.

Authors:  Maya T Kunkel; Qiang Ni; Roger Y Tsien; Jin Zhang; Alexandra C Newton
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

7.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

8.  In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.

Authors:  Barry J Collins; Maria Deak; J Simon C Arthur; Laura J Armit; Dario R Alessi
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

9.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.

Authors:  D R Alessi; M Deak; A Casamayor; F B Caudwell; N Morrice; D G Norman; P Gaffney; C B Reese; C N MacDougall; D Harbison; A Ashworth; M Bownes
Journal:  Curr Biol       Date:  1997-10-01       Impact factor: 10.834

10.  Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change.

Authors:  Christine C Milburn; Maria Deak; Sharon M Kelly; Nick C Price; Dario R Alessi; Daan M F Van Aalten
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

View more
  27 in total

1.  The GRP1 PH domain, like the AKT1 PH domain, possesses a sentry glutamate residue essential for specific targeting to plasma membrane PI(3,4,5)P(3).

Authors:  Carissa Pilling; Kyle E Landgraf; Joseph J Falke
Journal:  Biochemistry       Date:  2011-10-19       Impact factor: 3.162

Review 2.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 3.  Autoregulation of kinase dephosphorylation by ATP binding in AGC protein kinases.

Authors:  Tung O Chan; John M Pascal; Roger S Armen; Ulrich Rodeck
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

4.  Assembly of membrane-bound protein complexes: detection and analysis by single molecule diffusion.

Authors:  Brian P Ziemba; Jefferson D Knight; Joseph J Falke
Journal:  Biochemistry       Date:  2012-02-14       Impact factor: 3.162

Review 5.  Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain.

Authors:  E J Meuillet
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Effects of ethanol on conformational changes of Akt studied by chemical cross-linking, mass spectrometry, and (18)O labeling.

Authors:  Bill X Huang; Hee-Yong Kim
Journal:  ACS Chem Biol       Date:  2011-12-07       Impact factor: 5.100

7.  Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

Authors:  Alfredo Csibi; David Communi; Nathalie Müller; Serge P Bottari
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

8.  A novel pleckstrin homology domain-containing protein enhances insulin-stimulated Akt phosphorylation and GLUT4 translocation in adipocytes.

Authors:  Qiong L Zhou; Zhen Y Jiang; Allan S Mabardy; Claudia M Del Campo; David G Lambright; John Holik; Kevin E Fogarty; Juerg Straubhaar; Sarah Nicoloro; Anil Chawla; Michael P Czech
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

9.  Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.

Authors:  Wen-I Wu; Walter C Voegtli; Hillary L Sturgis; Faith P Dizon; Guy P A Vigers; Barbara J Brandhuber
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic.

Authors:  Nadine Dannemann; Jonathan Ross Hart; Lynn Ueno; Peter K Vogt
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.